GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (HKSE:02607) » Definitions » Sale Of Investment

Shanghai Pharmaceuticals Holding Co (HKSE:02607) Sale Of Investment : HK$31,063 Mil (TTM As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Sale Of Investment?

Shanghai Pharmaceuticals Holding Co's sale of investment for the three months ended in Mar. 2024 was HK$11,049 Mil. It means Shanghai Pharmaceuticals Holding Co gained HK$11,049 Mil from selling investments. Shanghai Pharmaceuticals Holding Co's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was HK$31,063 Mil.

Compared with last quarter (HK$3,903 Mil in Dec. 2023 ), Shanghai Pharmaceuticals Holding Co gained more money from selling investments in Mar. 2024 (HK$11,049 Mil).


Shanghai Pharmaceuticals Holding Co Sale Of Investment Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Sale Of Investment Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,414.95 5,697.26 4,026.29 33,799.65 30,474.21

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,641.28 3,846.17 12,264.87 3,903.39 11,048.66

Shanghai Pharmaceuticals Holding Co Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$31,063 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Pharmaceuticals Holding Co Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Pharmaceuticals Holding Co (HKSE:02607) Business Description

Traded in Other Exchanges
Address
No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.
Executives
Blackrock, Inc. 2201 Interest of corporation controlled by you
Shanghai Industrial Investment (holdings) Company Limited 2201 Interest of corporation controlled by you
Siic International Investment Company Limited 2101 Beneficial owner
Citigroup Inc. 2201 Interest of corporation controlled by you
Lsv Asset Management 2102 Investment manager

Shanghai Pharmaceuticals Holding Co (HKSE:02607) Headlines

No Headlines